Prognostic nomogram for acute pancreatitis after percutaneous biliary stent insertion in patients with malignant obstruction
Open Access
- 7 November 2022
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 22 (1) , 1-9
Abstract
This study aimed to develop and validate a nomogram to predict the risk of pancreatitis after percutaneous transhepatic biliary stent insertion (PTBS) in patients with malignant biliary obstruction (MBO). We enrolled 314 patients who underwent PTBS for MBO from March 2016 to July 2021 in this retrospective study. We used univariate analysis to identify potential risk factors, while a multivariate logistic regression model was employed to establish a nomogram for predicting the risk of pancreatitis. The discrimination and calibration of the nomogram were evaluated by estimating the area under the receiver operator characteristic curve (AUC) and by bootstrap resampling and visual inspection of the calibration curve. The clinical utility of the nomogram was assessed using decision curve analysis (DCA). After the procedure, 41 (13.1%) patients developed pancreatitis. Based on multivariate logistic regression analysis, young age (OR = 2.57, 95% CI 1.16 to 5.69), stent insertion across the papilla (OR = 6.47, 95% CI 2.66 to 15.70), and visualization of the pancreatic duct (OR = 15.40, 95% CI 6.07 to 39.03) were associated with an elevated risk of pancreatitis. Importantly, the performance of the nomogram was satisfactory, with an identical AUC (0.807, 95% CI 0.730 to 0.883) and high-level agreement between predicted and observed probabilities as suggested in calibration curves. The DCA curve subsequently confirmed the clinical utility. A predictive nomogram for pancreatitis after PTBS in patients with MBO was successfully established in the present study.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trialThe Lancet, 2016
- Comparison of Adverse Events for Endoscopic vs Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction in an Inpatient National CohortJAMA Oncology, 2016
- Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trialBMC Gastroenterology, 2015
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Internal‐external percutaneous transhepatic biliary drainage for malignant biliary obstruction: a retrospective analysisJournal of Medical Imaging and Radiation Oncology, 2010
- Nomograms for staging, prognosis, and predicting treatment outcomesCancer, 2009
- Acute pancreatitis: an under-recognized risk of percutaneous transhepatic distal biliary interventionHPB, 2006
- Natural β-Carotene for the Prevention of Post-ERCP PancreatitisPancreas, 2004
- Post-ERCP Pancreatitis and Hyperamylasemia: Patient-Related and Operative Risk FactorsEndoscopy, 2002
- Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis?Gastrointestinal Endoscopy, 1997